Extended Spectrum -Lactamase Mediated Resistance in Escherichia Coli in a Tertiary Care
Abstract
Background: ESBL occur mostly in Enterobacteriaceae e.g. Escherichia coli. ESBLs are clinically important because they
destroy cephalosporinÂ’s, work horse hospital antibiotics, given as first line agents to many severely ill patients. Delayed
recognition and inappropriate treatment of severe infections caused by ESBL producers with cephalosporin has been
associated with increased mortality. ESBL-mediated resistance is not always obvious in vitro to all cephalosporin. Many ESBL
producers are multi -resistant to non-B-Lactam antibiotics such as quinolones and amino glycosides, narrowing treatment
options. Some producers achieve outbreak status spreading among patients and locals, perhaps owing to particular
pathogenicity traits.
Methods: A total of 221 Escherichia coli isolates from different clinical specimens during the period of August 2005 to July
2007, were screened for potential ESBL activity. These strains were isolated from different clinical specimens like urine, blood,
sputum, pus and other body fluids which were received in the bacteriological division of microbiology.
Results: Two hundred and twenty one Escherichia coli isolates were isolated from different clinical specimens like urine, blood,
sputum, pus and other body fluids submitted for both in and out-patients of the hospital during the period August2005 to July
2007. All of them were subjected to screening by using ceftazidime, cefotaxime or ceftriaxone.
Two hundred and eleven were positive for potential ESBL producers out of 221. 95.4%of E. coli (211/221) were screen positive
which were subjected to confirmatory tests
Conclusion: Maximum number of ESBLs was from in-patients followed by out-patients. The out-patient presence of ESBL is of
main concern as it is now come to the alert of the physician that ESBL is spreading fast in the community and responsible for
community-acquired ESBLs and maximum number being from urine specimen
destroy cephalosporinÂ’s, work horse hospital antibiotics, given as first line agents to many severely ill patients. Delayed
recognition and inappropriate treatment of severe infections caused by ESBL producers with cephalosporin has been
associated with increased mortality. ESBL-mediated resistance is not always obvious in vitro to all cephalosporin. Many ESBL
producers are multi -resistant to non-B-Lactam antibiotics such as quinolones and amino glycosides, narrowing treatment
options. Some producers achieve outbreak status spreading among patients and locals, perhaps owing to particular
pathogenicity traits.
Methods: A total of 221 Escherichia coli isolates from different clinical specimens during the period of August 2005 to July
2007, were screened for potential ESBL activity. These strains were isolated from different clinical specimens like urine, blood,
sputum, pus and other body fluids which were received in the bacteriological division of microbiology.
Results: Two hundred and twenty one Escherichia coli isolates were isolated from different clinical specimens like urine, blood,
sputum, pus and other body fluids submitted for both in and out-patients of the hospital during the period August2005 to July
2007. All of them were subjected to screening by using ceftazidime, cefotaxime or ceftriaxone.
Two hundred and eleven were positive for potential ESBL producers out of 221. 95.4%of E. coli (211/221) were screen positive
which were subjected to confirmatory tests
Conclusion: Maximum number of ESBLs was from in-patients followed by out-patients. The out-patient presence of ESBL is of
main concern as it is now come to the alert of the physician that ESBL is spreading fast in the community and responsible for
community-acquired ESBLs and maximum number being from urine specimen
Wani, K. A., Thakur, M. A., Siraj, F. A., Fomdia, B., Gulnaz, B., & Maroof, P. (2009). Extended Spectrum -Lactamase Mediated Resistance in Escherichia Coli in a Tertiary Care. International Journal of Health Sciences, 3(2). Retrieved from https://ijhs.qu.edu.sa/index.php/journal/article/view/4
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Copyright and license info is not available